These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 6758376)

  • 1. On immunosurveillance in human cancer.
    Thomas L
    Yale J Biol Med; 1982; 55(3-4):329-33. PubMed ID: 6758376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunosuppression mechanism affecting the development of neoplasms].
    Rupniewska ZM; Kurowska M
    Pol Tyg Lek; 1980 Mar; 35(12):455-7. PubMed ID: 6966796
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction: Modification of immunity and carcinogenesis.
    Stjernswärd J
    Natl Cancer Inst Monogr; 1972 Dec; 35():149-56. PubMed ID: 4572823
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunological deficiency syndromes, immunosuppression by drugs and occurrence of neoplasms: a casual association?].
    Dammacco F; Iodice G; Romagno D; Campobasso N
    Ric Clin Lab; 1985; 15 Suppl 2():11-23. PubMed ID: 4095454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and dermatoscopic fading of post-transplant eruptive melanocytic nevi after suspension of immunosuppressive therapy.
    Piaserico S; Alaibac M; Fortina AB; Peserico A
    J Am Acad Dermatol; 2006 Feb; 54(2):338-40. PubMed ID: 16443071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoreactivity in tumor growth].
    Fel' VIa
    Vopr Onkol; 1987; 33(4):99-106. PubMed ID: 3296438
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosurveillance and cancer: epidemiologic observations.
    Fraumeni JF; Hoover R
    Natl Cancer Inst Monogr; 1977 Dec; 47():121-6. PubMed ID: 349400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulatory T cells in tumor immunity.
    Terabe M; Berzofsky JA
    Curr Opin Immunol; 2004 Apr; 16(2):157-62. PubMed ID: 15023407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of major histocompatibility complex in genetic regulation of immunologic responsiveness.
    Benacerraf B
    Transplant Proc; 1977 Mar; 9(1):825-31. PubMed ID: 325816
    [No Abstract]   [Full Text] [Related]  

  • 10. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Solid tumors after kidney transplantation].
    Moal MC
    Nephrol Ther; 2008 Oct; 4 Suppl 3():S214-7. PubMed ID: 19000890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer despite immunosurveillance: immunoselection and immunosubversion.
    Zitvogel L; Tesniere A; Kroemer G
    Nat Rev Immunol; 2006 Oct; 6(10):715-27. PubMed ID: 16977338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressed immunity and the development of cancer.
    Penn I
    Cancer Detect Prev; 1994; 18(4):241-52. PubMed ID: 7982234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancer in organ transplanted patients].
    Pfeffer PF
    Tidsskr Nor Laegeforen; 1999 Oct; 119(25):3792-4. PubMed ID: 10574060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients.
    Ho WL; Murphy GM
    Br J Dermatol; 2008 Feb; 158(2):217-24. PubMed ID: 18070205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fresh look at tumor immunosurveillance and immunotherapy.
    Smyth MJ; Godfrey DI; Trapani JA
    Nat Immunol; 2001 Apr; 2(4):293-9. PubMed ID: 11276199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
    Valantine H
    J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of the self/non-self-survey in the defense against cancer: potential for chemoprevention?
    Sharma RA; Browning MJ
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):5-22. PubMed ID: 15978831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of cancer after immunosuppressive treatment for heart transplantation.
    Ippoliti G; Rinaldi M; Pellegrini C; Viganò M
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):101-13. PubMed ID: 15979322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-gamma-dependent type 1 immunity is crucial for immunosurveillance against squamous cell carcinoma in a novel mouse carcinogenesis model.
    Wakita D; Chamoto K; Ohkuri T; Narita Y; Ashino S; Sumida K; Nishikawa H; Shiku H; Togashi Y; Kitamura H; Nishimura T
    Carcinogenesis; 2009 Aug; 30(8):1408-15. PubMed ID: 19509217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.